Bertin Philippe
CHU Dupuytren, Service de Thérapeutique et de Rhumatologie, Limoges.
Presse Med. 2006 Sep;35 Suppl 1:5-9. doi: 10.1016/S0755-4982(06)74935-1.
Analysis of national data from the health ministry programme of reduction of the cardiovascular risks (2002-2005) shows a high frequency of cardiovascular disease and cardiovascular risk factors in the general population. It is of interest to analyse these data in relation to the practice of rheumatology. In addition, the frequency of cardiovascular pathologies is higher in patients with rheumatoid arthritis and spondylarthropathy. These notions are also very important since these two populations are often treated with non-steroidal anti-inflammatory drugs for a long duration. General knowledge shown in this article concerning the cardiovascular risk factors and co-morbidities in the patients with rheumatic pathologies allows, within the context of a therapeutic decisional strategy in rheumatology, a better estimation of the individual benefit/risk ratio of each prescription and more particularly that of non-steroidal anti-inflammatory drugs.
对卫生部降低心血管风险计划（2002 - 2005年）的全国数据进行分析后发现，普通人群中心血管疾病和心血管风险因素的出现频率很高。结合风湿病的实际情况来分析这些数据很有意义。此外，类风湿关节炎和脊柱关节病患者中心血管疾病的发病率更高。由于这两类人群经常长期使用非甾体抗炎药进行治疗，所以这些观念也非常重要。本文中展示的关于风湿性疾病患者心血管风险因素和合并症的一般知识，在风湿病治疗决策策略的背景下，有助于更好地评估每个处方的个体获益/风险比，尤其是非甾体抗炎药的获益/风险比。
